-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Cannabis Bioscience International Holdings, Inc. quarterly and annual Revenues in USD history and change rate from 30 Nov 2022 to 30 Nov 2025.
- Cannabis Bioscience International Holdings, Inc. Revenues for the quarter ending 30 Nov 2025 was $53,266, a 28% decline year-over-year.
- Cannabis Bioscience International Holdings, Inc. Revenues for the twelve months ending 30 Nov 2025 was $127,353, a 65% decline year-over-year.
- Cannabis Bioscience International Holdings, Inc. annual Revenues for 2024 was $303,022, a 22% increase from 2023.
- Cannabis Bioscience International Holdings, Inc. annual Revenues for 2023 was $248,841, a 21% decline from 2022.